Analytics

Articles

Also, NicOx and DSM make manufacture and supply pact for naproxcinod drug substance; NovaRx appointed Norrie Russell president and COO; more...

Company and People Notes: BMS and AstraZeneca Expand Collaboration; Johnathan Knowles to Retire from Roche in 2009; More...

Also, AstraZeneca announces changes to its supply chain operations; Christian Velmer appointed head of Wyeth Canada; More...

Company and People Notes: Lilly Completes Acquisition of ImClone; Novocell CEO to Lead The Juvenile Diabetes Research Foundation; More...

Pharmaceutical Technology is pleased to recognize the winners of its Innovations in Pharma Science Awards.

Innovations in Pharma Science

Also, Johnson & Johnson will acquire Omrix Biopharmaceuticals for $438 million; Charles River Laboratories promoted Foster Jordan to corporate senior VP of endotoxin and microbial detection products; more...

Company and People Notes: King Acquires Alpharma for $1.6 B; Wyeth Names Michael Kamarck President of Technical Operations & Product Supply; More...

Angie Drakulich was editorial director of Pharmaceutical Technology.

Advancements add yet another challenge for industry's already overextended regulatory body.

Complex Science

Also, Alpharma advises shareholders to reject King's offer; ImClone rejects raised BMS offer; Immunogen appoints Daniel M. Junius, more...

Company and People Notes: GSK to Cut up to 850 Jobs; Zerhouni to Leave NIH; More...

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

The growth and globalization of the pharmaceutical supply chain make risk assessment more important than ever for pharmaceutical manufacturers. The authors describe a program to identify, prioritize, mitigate, and communicate risks in manufacturer–supplier relationships.

Risk Management within the Global Supply Chain

Also, Zentiva accepts Sanofi's increased takeover bid, Oriel Therapeutics appoints Richard Fuller CEO, more...

Company and People Notes: Committee on Energy and Commerce Expands Ranbaxy Probe; Eli Lilly Appoints John C. Lechleiter Chairman of the Board; More...

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

EPedigree, track-and-trace technologies, and other tools for optimizing supply-chain management are of increasing importance to the pharmaceutical industry. The author examines the current regulatory and legislative framework for ePedigree for finished drug products as well as proposals to require electronic statements for pharmaceutical ingredients.

Epedigree in the Pharmaceutical Supply Chain

Actavis Totowa LLC, the US subsidiary of the generic drug manufacturer Actavis Group, is announcing a voluntary recall to the retail level of all drug products manufactured at its Little Falls, New Jersey, facility. This is a precautionary, voluntary action by Actavis following an inspection conducted by the Food and Drug Administration earlier this year.

Drug Substance Analysis